Inozyme Pharma Inc (INZY) — Working Capital to Net Assets Ratio
Inozyme Pharma Inc (INZY) has a Working Capital to Net Assets ratio of 159.9% as of March 2025. Working capital of $50.86 Million (current assets of $93.64 Million minus current liabilities of $42.78 Million) is measured against net assets of $31.80 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Inozyme Pharma Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Inozyme Pharma Inc Working Capital to Net Assets (2018–2024)
This chart shows how Inozyme Pharma Inc's Working Capital to Net Assets ratio has evolved across 7 annual periods from 2018 to 2024. As of March 2025, the ratio stands at 159.9%, reflecting working capital of $50.86 Million against net assets of $31.80 Million USD. See operational self-sufficiency of Inozyme Pharma Inc to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Inozyme Pharma Inc (2018–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Inozyme Pharma Inc from 2018 to 2024, covering 7 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Inozyme Pharma Inc stock valuation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 150.1% | $86.78 Million | $57.83 Million | $120.68 Million | $33.90 Million | ▲ +20.8 pp |
| 2023 | 129.2% | $181.56 Million | $140.48 Million | $196.25 Million | $14.69 Million | ▲ +30.7 pp |
| 2022 | 98.6% | $116.68 Million | $118.39 Million | $131.39 Million | $14.71 Million | ▲ +3.6 pp |
| 2021 | 94.9% | $103.71 Million | $109.27 Million | $115.34 Million | $11.63 Million | ▲ +5.7 pp |
| 2020 | 89.2% | $141.01 Million | $158.10 Million | $150.98 Million | $9.97 Million | ▲ +222.3 pp |
| 2019 | -133.1% | $44.22 Million | $-33.22 Million | $47.46 Million | $3.24 Million | ▲ +161.5 pp |
| 2018 | -294.6% | $40.88 Million | $-13.88 Million | $43.27 Million | $2.39 Million | — |